Akouos Inc logo

AKUS - Akouos Inc News Story

$10.87 -0.6  -5.1%

Last Trade - 30/07/21

Sector
Healthcare
Size
Small Cap
Market Cap £282.8m
Enterprise Value £77.6m
Revenue £n/a
Position in Universe 3936th / 7015

Akouos to Present at Bank of America 2021 Virtual Healthcare Conference

Fri 7th May, 2021 12:00pm
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210507:nGNXbfM3rv&default-theme=true


BOSTON, May 07, 2021 (GLOBE NEWSWIRE) -- Akouos, Inc. (“Akouos”) (NASDAQ:
AKUS), a precision genetic medicine company dedicated to developing potential
gene therapies for individuals living with disabling hearing loss worldwide,
today announced that Manny Simons, Ph.D., M.B.A., co-founder, president, and
chief executive officer of Akouos, will participate in a fireside chat at the
Bank of America 2021 Virtual Healthcare Conference on Wednesday, May 12 at
2:00 p.m. EDT.

A live webcast of the fireside chat will be available on the investors section
of the company’s website at www.akouos.com. To access the webcast, please go
to the Akouos website approximately 15 minutes prior to the start time to
ensure adequate time for any software downloads that may be required. A replay
of the webcast will be available on Akouos’s website for 30 days following
the conference.

About Akouos

Akouos is a precision genetic medicine company dedicated to developing gene
therapies with the potential to restore, improve, and preserve high-acuity
physiologic hearing for individuals living with disabling hearing loss
worldwide. Leveraging its precision genetic medicine platform that
incorporates a proprietary adeno-associated viral (AAV) vector library and a
novel delivery approach, Akouos is focused on developing precision therapies
for forms of sensorineural hearing loss. Headquartered in Boston, Akouos was
founded in 2016 by leaders in the fields of neurotology, genetics, inner ear
drug delivery, and AAV gene therapy.

Contacts

Media:
Katie Engleman, 1AB
katie@1abmedia.com

Investors:
Courtney Turiano, Stern Investor Relations
Courtney.Turiano@sternir.com

(https://www.globenewswire.com/NewsRoom/AttachmentNg/60016ca1-7c76-4789-b4d3-ddc26ee7bd65)



GlobeNewswire, Inc. 2021
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.